Synthesis and antibacterial activity of novel 5-(4-methyl-1H-1,2,3-triazole) methyl oxazolidinones

被引:89
作者
Phillips, Oludotun A. [1 ]
Udo, Edet E. [2 ]
Abdel-Hamid, Mohammed E. [1 ]
Varghese, Reny [1 ]
机构
[1] Kuwait Univ, Dept Pharmaceut Chem, Fac Pharm, Safat 13110, Kuwait
[2] Kuwait Univ, Fac Med, Dept Microbiol, Safat 13110, Kuwait
关键词
Antibacterial; Linezolid; Monoamine oxidase; PH-027; 5-(4-Methyl-1,2,3-triazole)methyl oxazolidinone; Oxazolidinone; 5-TRIAZOLYLMETHYL OXAZOLIDINONES; NOSOCOMIAL INFECTIONS; AGENTS; 1,2,3-TRIAZOLES; IDENTIFICATION; AMINES;
D O I
10.1016/j.ejmech.2009.03.024
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 5-(4-methyl-1,2,3-triazole)methyl oxazolidinones were synthesized and tested for their antibacterial activity against a panel of Gram-positive and Gram-negative clinical isolates in comparison with linezolid and vancomycin. Most of the compounds demonstrated strong to moderate in vitro antibacterial activity against susceptible and resistant Gram-positive pathogenic bacteria. Antibacterial activity varied with substitutions at the phenyl C4 position with bulky alkylcarbonyl and alkoxycarbonyl substitutions on the piperazine N4 being detrimental to antibacterial activity. Whereas the presence of the 4-methyl-1,2,3-triazole moiety in the acyl-piperazine containing analogs resulted in increased protein binding, and decreased antibacterial activity particularly against Streptococcus pneumoniae strains. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:3217 / 3227
页数:11
相关论文
共 24 条
  • [1] [Anonymous], 1997, M7A4 NCCLS
  • [2] *ANT RES PREV IN, 2006, AM J INFECT CONTRO S, V34, pA1
  • [3] Oxazolidinone structure-activity relationships leading to linezolid
    Barbachyn, MR
    Ford, CW
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (18) : 2010 - 2023
  • [4] Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant Gram-positive bacterial infections
    Brickner, SJ
    Hutchinson, DK
    Barbachyn, MR
    Manninen, PR
    Ulanowicz, DA
    Garmon, SA
    Grega, KC
    Hendges, SK
    Toops, DS
    Ford, CW
    Zurenko, GE
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (03) : 673 - 679
  • [5] National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004
    Cardo, D
    Horan, T
    Andrus, M
    Dembinski, M
    Edwards, J
    Peavy, G
    Tolson, J
    Wagner, D
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2004, 32 (08) : 470 - 485
  • [6] Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases
    Fauci, AS
    Touchette, NA
    Folkers, GK
    [J]. EMERGING INFECTIOUS DISEASES, 2005, 11 (04) : 519 - 525
  • [7] European status of resistance in nosocomial infections
    Goossens, H
    [J]. CHEMOTHERAPY, 2005, 51 (04) : 177 - 181
  • [8] Gravestock MB, 2005, CURR OPIN DRUG DISC, V8, P469
  • [9] New carbon-linked azole oxazolidinones with improved potency and pharmacokinetics
    Hauck, Sheila I.
    Cederberg, Christer
    Doucette, Amanda
    Grosser, Lena
    Hales, Nell J.
    Poon, Grace
    Gravestock, Michael B.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (02) : 337 - 340
  • [10] Huisgen R., 1984, 1 3 DIPOLAR CYCLOADD, V1, P55